Impact of reversible inhibitor binding to protein Arginine Deiminase Type 4 (PAD4): Molecular Dynamics Simulation and Mmpbsa Calculation
PAD4 catalyses the conversion of peptidylarginine into peptidylcitrulline. Overexpression of PAD4 and the peptidylcitrulline products have been reported in various diseases including rheumatoid arthritis and cancers. GSK199 is the first PAD4 selective reversible inhibitor discovered. The impact of G...
Saved in:
Main Authors: | Zainal Fithri, Helmi Husaini, Ibrahim, Zalikha, Ali, Ernie Zuraida |
---|---|
Format: | Proceeding Paper |
Language: | English English |
Published: |
2022
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/107904/14/107904_Impact%20of%20reversible%20inhibitor%20binding%20to%20protein%20Arginine_abstract.pdf http://irep.iium.edu.my/107904/15/107904_Impact%20of%20reversible%20inhibitor%20binding%20to%20protein%20Arginine_slides.pdf http://irep.iium.edu.my/107904/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of GSK199 and GSK106 binding on protein arginine deiminase IV stability and flexibility: a computational approach
by: Zainal Fithri, Helmi Husaini, et al.
Published: (2023) -
In-silico identification of potential protein arginine deiminase IV (PAD4) inhibitors = Pengenalpastian in-silico yang berpotensi sebagai perencat protin arginina deiminase IV
(PAD4))
by: Ibrahim, Zalikha, et al.
Published: (2016) -
In-silico identification of potential Protein Arginine Deiminase IV (PAD4) inhibitors
by: Ibrahim, Zalikha, et al.
Published: (2016) -
Molecular characterization, biological activity, and in silico study of 2-(3,4-dimethoxyphenyl)-3-(4-fluorophenyl)-6-methoxy-4H-chromen-4-one as a novel selective COX-2 inhibitor
by: Rullah, Kamal, et al.
Published: (2015) -
Structure-based design of peptide inhibitors for Protein Arginine Deiminase Type IV (PAD4)
by: Teo, Chian Ying, et al.
Published: (2018)